Erythromycin Cyclocarbonate

环酯红霉素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameErythromycin Cyclocarbonate
Drug Alias Name12-碳酸酯Davercin红霉素 11冠沙
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2003/01/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChina Resources Double-Crane Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeD10AF02J01FA01S01AA17
Related LinksN/A